Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in T2D patients with CAD and leukocyte activation
NCT03376698Phase 2Completed
- Sponsor
- University of the Ryukyus
- Start
- Jun 2017
- Primary completion
- Mar 2022
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in coronary artery disease (CAD), sponsored by University of the Ryukyus. Started Jun 2017; status: completed.
02
Drugs
colchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03376698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03376698.